Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00550043 · ClinicalTrials.gov registry record · Phase 2

A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis

A Phase 2 study of Rheumatoid Arthritis, sponsored by Incyte Corporation.

Completed
Registry status
Phase 2
Development phase
50
Enrollment target
15
Study locations

NCT00550043 is a Phase 2 study of Rheumatoid Arthritis that has completed, run by Incyte Corporation. The registered enrollment target is 50 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The trial reports 15 study locations across 9 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00550043, a Phase 2 study of Rheumatoid Arthritis, has completed, sponsored by Incyte Corporation.

COMPLETED
Registry status
Phase 2
Development phase
50 participants
Enrollment target
15
Study locations

Study Summary

The purpose of this study is to understand the safety and tolerability of INCB018424 in patients with rheumatoid arthritis

Conditions Studied

Rheumatoid Arthritis

Interventions

  • DRUG Placebo
  • DRUG INCB018424

Study Locations (15)

Ohio

  • - Mayfield Village,
  • - Middleburg Heights
  • - Perrysburg

Other

  • - Elblag
  • - Gmina Końskie
  • - Warsaw

Florida

  • - Gainesville
  • - Palm Harbor

Tennessee

  • - Hixson
  • - Memphis

Alabama

  • - Huntsville

California

  • - Upland

Montana

  • - Kalispell

North Carolina

  • - Hickory

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2007-10
Est. Completion 2008-09
Phase Phase 2

Sponsor

Incyte Corporation

239 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00550043

The ClinicalTrials.gov registry entry for NCT00550043 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (99% lower). The listed sponsor is Incyte Corporation, which has 239 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00550043 reports 15 study locations spanning 9 distinct geographic areas - top geographies include Ohio, Other, Florida.

Frequently Asked Questions

What is clinical trial NCT00550043 about?

NCT00550043 is a clinical study titled "A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis". The purpose of this study is to understand the safety and tolerability of INCB018424 in patients with rheumatoid arthritis

What is the current status of trial NCT00550043?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 50 participants. The study started on 2007-10. Estimated completion is 2008-09.

What conditions does trial NCT00550043 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis.

What interventions are being tested in trial NCT00550043?

The interventions under investigation include: Placebo (DRUG), INCB018424 (DRUG).

Who is sponsoring clinical trial NCT00550043?

This trial is sponsored by Incyte Corporation, which has 239 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00550043 being conducted?

This trial has 15 study locations across Alabama, California, Florida, Montana, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Rheumatoid Arthritis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.